Quantcast

Latest Osteoarthritis Stories

2014-02-25 23:29:42

Arthritic pain relief is possible without medication. SuperSlow Zone, a Premier Personal Wellness and Exercise Studio, and is now excited to share their insight into how physical activity helps provide relief to those with arthritic pain. Omaha, NE (PRWEB) February 25, 2014 Arthritic pain relief is possible without medication. SuperSlow Zone, a Premier Personal Wellness and Exercise Studio, is now excited to share their insight into how physical activity helps provide relief to those...

2014-02-25 20:21:43

THE JOURNAL ENTITLED "NATURE REVIEWS RHEUMATOLOGY" HIGHLIGHTS THIS PUBLICATION MARIETTA, Ga., Feb. 25, 2014 /PRNewswire/ -- MiMedx Group, Inc. (NASDAQ: MDXG), an integrated developer, manufacturer and marketer of patent protected regenerative biomaterials and bioimplants processed from human amniotic membrane, announced today a MiMedx-sponsored study from Georgia Institute of Technology has been published in Arthritis Research & Therapy. The article, titled "Intra-articular...

2014-02-23 23:03:19

Let Chronic Pain from Arthritis and Everyday Life Be a Thing of the Past Boca Raton, FL (PRWEB) February 23, 2014 Syn-flex America, Inc., the makers of liquid Glucosamine supplements designed for those suffering from osteoarthritis, family pets, and athletes, is pleased to announce that Revnutrition.com will now be retailing it’s revolutionary supplement. “For people with joint issues, it can be difficult to play sports, be active with their children or grandchildren or even go for a...

2014-02-20 12:28:33

OAKLAND, Calif., Feb. 20, 2014 /PRNewswire/ -- OrthoTrophix, Inc., a privately held biopharmaceutical company, announced today that the Company started a Phase 2 clinical study of its cartilage repair therapeutic agent, TPX-100, with knee osteoarthritis patients in the U.S. The Company also announced that it had successfully closed the second and last tranche of its Series A preferred stock financing. (Logo: http://photos.prnewswire.com/prnh/20140220/SF68860LOGO) The purpose of...

2014-02-18 08:31:01

GREENWOOD VILLAGE, Colo., Feb. 18, 2014 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) today announced it has completed enrollment and dosing of 500 patient in the pivotal trial of Ampion((TM)) for the treatment of acute osteoarthritis of-the-knee (OAK). http://clinicaltrials.gov/ct2/show/NCT02024529?term=ampio&rank=1 (Logo: http://photos.prnewswire.com/prnh/20120516/MM09116LOGO) Dr. Vaughan Clift, Ampio's Chief Regulatory Officer, explained: "This phase III,...

2014-02-10 08:26:43

MISSISSAUGA, ON, Feb. 10, 2014 /PRNewswire/ - Nuvo Research Inc. (TSX: NRI), a specialty pharmaceutical company with a diverse portfolio of topical and immunology products today announced the U.S. commercial launch of PENNSAID (diclofenac sodium topical solution) 2% w/w (PENNSAID 2%) by its U.S. commercial licensee Mallinckrodt (NYSE:MNK). PENNSAID 2% is the first twice per day topical non-steroidal anti-inflammatory drug (NSAID) approved for use in the United States for the...

2014-02-04 08:28:44

GREENWOOD VILLAGE, Colo., Feb. 4, 2014 /PRNewswire/ -- Ampio Pharmaceuticals, Inc. (NYSE MKT: AMPE) ("Ampio" or the "Company") today announced that the article reporting the results of its initial pivotal clinical trial of Ampion(TM) for the treatment of pain due to Osteoarthritis of the knee (OAK), was published in PLOS ONE, an international, rigorously peer-reviewed, open-access, online publication which covers primary research from any discipline within science and medicine, and is...

2014-01-17 08:22:56

- Mallinckrodt to Launch PENNSAID 2% in the U.S. in Q1 2014 - MISSISSAUGA, ON, Jan. 17, 2014 /PRNewswire/ - Nuvo Research Inc. (TSX:NRI), a specialty pharmaceutical company with a diverse portfolio of products in the areas of topical pain and immunology today announced that the U.S. Food and Drug Administration (FDA) has approved Mallinckrodt's New Drug Application for PENNSAID(®) (diclofenac sodium topical solution) 2% w/w (PENNSAID 2%). PENNSAID 2% is a follow-on product to...

2014-01-16 23:31:02

Cellular Life Research Center has awarded it's Advanced Research Recognition award to PIMTforLife. In clinical trials, patients taking PIMTforLife, an all-natural anti-aging tablet, have shown a dramatic reverse in signs of aging in as little time as three weeks. St. Petersburg, FL (PRWEB) January 16, 2014 PIMTforLife is the number one anti-aging tablet recognized by the Cellular Life Research Center for its unique and highly effective utilization of the PIMT enzyme and is also now...

Smart Hydrogel Delivers Medicine On Demand
2014-01-16 08:46:10

Rebekah Eliason for redOrbit.com – Your Universe Online A new study from the University of Delaware has led to the development of a 'smart' hydrogel that is capable of delivering medicine based on response to mechanical force. For the last several decades, many hydrogels have been created that release medicine in response to pH, temperature, DNA, light and other stimuli. Xinqiao Jia, UD professor of materials science and engineering and biomedical engineering said, “The idea of a...


Word of the Day
callithump
  • A somewhat riotous parade, accompanied with the blowing of tin horns, and other discordant noises; also, a burlesque serenade; a charivari.
'Callithump' is a back-formation of 'callithumpian,' a 'fanciful formation' according to the Oxford English Dictionary. However, the English Dialect Dictionary, says 'Gallithumpians' is a Dorset and Devon word from the 1790s that refers to 'a society of radical social reformers' or 'noisy disturbers of elections and meetings.'
Related